March 2004
American Academy of Neurology
American Academy of Neurology presents 56th Annual Meeting in San Francisco, April 24 - May 1, 2004World's largest annual gathering of neurologistsMore than 10,000 are expected to attend the American Academy of Neurology 56th Annual Meeting in San Francisco, April 24 � May 1, 2004.
Held in the Moscone Convention Center, the very latest research findings on dementia, Parkinson's disease, stroke, epilepsy, headache, multiple sclerosis and other neurological disorders will be included in more than 1,300 scientific studies presented as platform and poster sessions.
"The highly regarded science program at the Annual Meeting draws worldwide interest and provides neurologists access to cutting-edge research," said AAN president Sandra F. Olson, MD. "The 2004 scientific program covers the full spectrum of neurology, from prevention to diagnosis and treatment."
Key science presentations will be presented at four plenary sessions, starting with the Presidential Plenary Session on April 27 at 9:00 a.m. Eric R. Kandel, MD, of Columbia University, New York, N.Y., will give the Presidential Lecture on "Molecular Mechanisms for the Persistence of Memory Storage."
The Contemporary Clinical Issues and Case Studies Plenary Session will take place on April 28 at 9:00 a.m. A new addition to this session will be three case presentations focusing on multiple sclerosis, Parkinson's disease and the effect of estrogen in neurological disease.
On April 29 at 9:00 a.m., several physician-scientists will outline recent research findings, along with the clinical implications, during the Frontiers in Clinical Neurosciences Plenary Session: Beyond the Decade of the Brain. Among the presentations will be "Markers and Mediators of Neuronal Deficits in Dementia" by Lennart Mucke, MD, of the University of California, San Francisco.
The Scientific Program Highlights Plenary Session will conclude the plenary sessions on April 30 beginning at 5:15 p.m. after all educational programs have ended. As chair of the AAN Science Committee, John H. Noseworthy, MD, of the Mayo Clinic, Rochester, Minn., will moderate a review of the most critical new research presented during this meeting.
From Monday, April 26 through Thursday, April 29, the on-site Press Room (room 214 of the Moscone Convention Center) will host a variety of media briefings based on certain abstracts presented during the meeting. The Press Room will also host a special press conference on epilepsy and anti-epileptic drugs on Monday, April 26 at 10:00 a.m. (PST).
The American Academy of Neurology, an association of more than 19,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, autism and multiple sclerosis.
For more information about the American Academy of Neurology, visit www.aan.com.
| |
|